GSK, Johnson & Johnson Invest in $200m Venture Fund

March 22, 2012

March 23, 2012 | GlaxoSmithKline and Johnson & Johnson are forming a $200 million fund to invest in early-stage biotech companies. Each pharma will contribute $50 million while Index Ventures will contribute $100 million. NJ.com